KRAS and lung adenocarcinoma: KRAS mutations, more than 80% of which are G12 mutations, are frequently found in pancreatic ductal adenocarcinoma (> 90%), colorectal adenocarcinoma (> 40%), and lung adenocarcinoma (approximately 30%).